5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial.
| Image |  |
|---|---|
| Description | scientific article published on 11 May 2016 |
| Author/s |
author: Giulia Valeria Bianchi Ana Lluch Seock-Ah Im Elżbieta Starosławska Tadeusz Pieńkowski Luca Gianni |
| Publication date | May 11, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |